Applied Therapeutics (APLT)

• Market cap: $163M
• 1 day: 0%
• 5 days: -18.12%
• 1 month: 86.81%
• 3 months: 151.11%
• 6 months: 176.15%
• Year to date: 25.81%
• 1 year: -87.22%
• 5 years: -93.59%
• 10 years: -87.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Employees: 32